Cargando…
PSAT156 Abaloparatide Implementation and Follow-Up: Real-World Results of a Pharmacist-Run Anabolic Osteoporosis Clinic
INTRODUCTION: Osteoporosis, the most common bone disorder worldwide, is associated with increased morbidity and mortality. Available treatments include antiresorptive agents and anabolic therapies. Anabolic therapies are indicated in patients at high risk of osteoporotic fracture. There are challeng...
Autores principales: | Arceri, Veronica, Busch, Robert, Kane, Michael, Quinn, Hugh, Racz, Michael, Telese, Mallory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624828/ http://dx.doi.org/10.1210/jendso/bvac150.404 |
Ejemplares similares
-
OR03-1 The Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis and Osteoarthritis
por: Lane, Nancy, et al.
Publicado: (2019) -
PSAT157 Efficacy of Bisphosphanate Treatment in Pediatric Patients with Osteoporosis Due to Immobilization
por: Lee, Myeongseob
Publicado: (2022) -
RF30 | PSAT138 Romosozumab-aqqg in the Treatment of Osteoporosis in a Patient with Hypophosphatasia
por: Khanjee, Naveed, et al.
Publicado: (2022) -
RF06 | PSAT154 Osteoporosis Likely Increases the Risk of Dementia in Vietnamese Immigrants
por: Kim, Yu N, et al.
Publicado: (2022) -
PSAT182 Dilemmas in the Diagnosis and Management of Osteoporosis in a patient with Alkaptonuria: Successful Treatment with Teriparatide
por: Ebrahim, Ismail, et al.
Publicado: (2022)